Paul Tudor Jones's COLL Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 17,176 shares of Collegium Pharmaceutical, Inc. (COLL) worth $795,249, representing 0.00% of the portfolio. First purchased in 2017-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in COLL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 16,010 shares. Largest reduction occurred in Q2 2017, reducing 15,000 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Collegium Pharmaceutical (COLL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Collegium Pharmaceutical (COLL) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1,166 | Add 7.28% | 17,176 | $46.30 |
| Q3 2025 | +16,010 | New Buy | 16,010 | $34.99 |
| Q2 2017 | -15,000 | Sold Out | 0 | $0.00 |
| Q1 2017 | +15,000 | New Buy | 15,000 | $10.07 |
Paul Tudor Jones's Collegium Pharmaceutical Investment FAQs
Paul Tudor Jones first purchased Collegium Pharmaceutical, Inc. (COLL) in Q1 2017, acquiring 15,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Collegium Pharmaceutical, Inc. (COLL) for 4 quarters since Q1 2017.
Paul Tudor Jones's largest addition to Collegium Pharmaceutical, Inc. (COLL) was in Q3 2025, adding 16,010 shares worth $560,190.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 17,176 shares of Collegium Pharmaceutical, Inc. (COLL), valued at approximately $795,249.
As of the Q4 2025 filing, Collegium Pharmaceutical, Inc. (COLL) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Collegium Pharmaceutical, Inc. (COLL) was 17,176 shares, as reported at the end of Q4 2025.